{
    "physical_examinations": [
        {
            "date": "Not specified",
            "vital_signs": "Not specified",
            "relevant_findings": "Patient presented with short stature, height SDS -3.3 for age and sex.",
            "changes_over_time": "Growth retardation became obvious at the age of 5 3/12 years. Initial short stature diagnosis at age 6 years."
        },
        {
            "date": "Not specified",
            "vital_signs": "Not specified",
            "relevant_findings": "At age 7.2 years, height was 99 cm (SDS -5.9).",
            "changes_over_time": "Patient underwent pituitary function testing showing low peak levels of GH during sleep (3.2 ng/ml) and arginine stimulation (2.4 ng/ml)."
        },
        {
            "date": "Not specified",
            "vital_signs": "Not specified",
            "relevant_findings": "Patient II:1 referred for evaluation of short stature and had a small anterior pituitary gland occupying 50% of the fossa on CT scan.",
            "changes_over_time": "Human pituitary-derived GH was started but stopped in 1985; rhGH was later introduced and discontinued at age 16."
        },
        {
            "date": "Not specified",
            "vital_signs": "Not specified",
            "relevant_findings": "At retesting off GH at 16.6 years, peak GH levels were 5.8 ng/ml during arginine stimulation.",
            "changes_over_time": "IGF-I level at age 25 years was low at 101 ng/ml (normal range 127â€“360 ng/ml)."
        }
    ]
}